Publizoom

Award notice Supplies

Fármacos exclusivos

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
Consorci Corporació Sanitària Parc Taulí
Sabadell
Place of performance
Sabadell
Estimated value
€8,412,660 excl. VAT
Amount awarded
€529,065 excl. VAT
Bids received
1
Procedure
Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication
5 August 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Fármacos exclusivos

Awarded to

6 lots

  • EXC12 FÀRMACO EXCLUSIVO
  • EXC14 FÀRMACO EXCLUSIVO
  • EXC37 FÀRMACO EXCLUSIVO
  • EXC69 FÀRMACO EXCLUSIVO
  • EXC98 FÀRMACO EXCLUSIVO
  • LOTES DESIERTOS:EXC26-2936-39-41-43-46-55-60-81-96-99-990-992-993 FÀRMACO EXCLUSIVO

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€861,120
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 257 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 203199, con la empresa pfizer, s.l
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar · 22 October 2026
PFIZER, S.L €164,527,501
Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 203209, con la empresa takeda farmacéutica españa, s.a
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar · 22 October 2026
TAKEDA FARMACÉUTICA ESPAÑA, S.A. €4,010,802,463
Suministro de Eplontersen (WAINZUA) de distribución exclusiva . con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS DE MADRID · 22 October 2026
ASTRAZENECA FARMACÉUTICA SPAIN, S.A. €160,015
MEDICAMENTO CARVYKTI 3,2x10e6-1x10e8 células dispersión, CON DESTINO AL HOSPITAL UNIVERSITARIO DE LA PRINCESA
Hospital Universitario de la Princesa · 22 October 2026
JANSSENG-CILAG, S.A. €2,936,960
“Suministro IOMEPROL (IOMERON) Y HEPARINA SODICA 20 UI/ML (FIBRILIN) de distribución exclusiva con destino al servicio de Farmacia Hospital Clínico San Carlos de Madrid"
HOSPITAL CLINICO SAN CARLOS · 22 October 2026
LABORATORIOS FARMACEUTICOS ROVI, S.A. €224,016

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 543618-2026.